11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
Pacific Biosciences Of California Inc. (PACB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 33,290,137 | $124,838,014 | -4% | 0.86% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.40 | 40,000 | Director | 40,000 | 2024-03-06 | Filing | |
| $2.01 | 1 | Officer | 215,156 | 2018-09-01 | Filing | |
| $2.01 | 5,989 | Officer | 215,155 | 2018-03-01 | Filing | |
| $4.07 | 3,244 | Officer | 194,166 | 2017-09-01 | Filing | |
| $4.07 | 3,212 | Officer | 190,922 | 2017-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.87 | 2,968 | Officer | 217,216 | 2024-03-04 | Filing | |
| $4.87 | 9,186 | Officer | 1,668,826 | 2024-03-04 | Filing | |
| $4.87 | 5,275 | Officer | 712,260 | 2024-03-04 | Filing | |
| $4.87 | 14,177 | Officer | 2,596,670 | 2024-03-04 | Filing | |
| $5.96 | 33,560 | Officer | 876,611 | 2024-02-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,789,552 | $262,805,506 | 0% | |
| 2. | 24,642,666 | $241,744,552 | 0% | |
| 3. | 17,591,915 | $172,576,686 | 21.5% | |
| 4. | 13,200,375 | $129,627,683 | 1.24% | |
| 5. | 13,200,375 | $129,495,679 | 0.09% |
News See All
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
14 Best Beaten Down Stocks To Buy Right Now
In this piece, we will take a look at the 14 best beaten down stocks to buy right now.
5 Best Falling Stocks To Buy Right Now
In this piece, we will take a look at the five best falling stocks to buy now.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript
Pacific Biosciences of California, Inc. reports earnings inline with expectations. Reported EPS is $-0.31 EPS, expectations were $-0.31. Pacific Biosciences of California, Inc.
Top 11 CRISPR Stocks To Invest In
Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...
12 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds.
5 Best Genomics Stocks To Buy Now
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a gene editing company developing treatments for cancer and immune system diseases.
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Billionaire Hedge Funds
